Table 3 from Safety and Antitumor Activity of a Novel aCD25 Treg Depleter RG6292 as a Single Agent and in Combination with Atezolizumab in Patients with Solid Tumors
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接：
https://figshare.com/articles/dataset/Table_3_from_Safety_and_Antitumor_Activity_of_a_Novel_aCD25_Treg_Depleter_RG6292_as_a_Single_Agent_and_in_Combination_with_Atezolizumab_in_Patients_with_Solid_Tumors/28562757
下载链接
链接失效反馈官方服务：
资源简介：
Summary of key outcome parameters of study 2 (BP42595; RG6292 plus atezolizumab 1,200 mg every 3 weeks)
创建时间：
2025-03-10
